Vaccination strategies in patients with renal cell carcinoma.
Apr 2009 - Cancer Immunol. Immunother.; 58(7):1432-0851 [PMID:19360405]
[Asemissen AM] [Brossart P]

Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients.
Jun 2006 - Cancer Res.; 66(11):0008-5472 [PMID:16740731]
[Wierecky J] [Müller MR] [Wirths S] [Halder-Oehler E] [Dörfel D] [Schmidt SM] [Häntschel M] [Brugger W] [Schröder S] [Horger MS] [Kanz L] [Brossart P]

Dendritic cell-based cancer immunotherapy targeting MUC-1.
Dez 2005 - Cancer Immunol. Immunother.; 55(1):0340-7004 [PMID:15864588]
[Wierecky J] [Mueller M] [Brossart P]

Current status of vaccination therapy for leukemias.
Jan 2005 - Curr. Hematol. Rep.; 4(1):1541-0714 [PMID:15610663]
[Reichardt VL] [Brossart P]

Dendritic cells in clinical trials for multiple myeloma.
Dez 2004 - Methods Mol. Med.; 109:1543-1894 [PMID:15585918]
[Reichardt VL] [Brossart P]

DC-based immunotherapy of B-cell malignancies.
Feb 2004 - Cytotherapy; 6(1):1465-3249 [PMID:14985168]
[Reichardt VL] [Brossart P]

Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cells.
Okt 2003 - Haematologica; 88(10):1592-8721 [PMID:14555310]
[Reichardt VL] [Milazzo C] [Brugger W] [Einsele H] [Kanz L] [Brossart P]

Dendritic cells in vaccination therapies of malignant diseases.
Sep 2002 - Transfus. Apher. Sci.; 27(2):1473-0502 [PMID:12350054]
[Brossart P] [Brossart M D P]

Dendritic cells in cancer vaccines.
Nov 2001 - Exp. Hematol.; 29(11):0301-472X [PMID:11698120]
[Brossart P] [Wirths S] [Brugger W] [Kanz L]